By loading the video, you agree to YouTube’s privacy policy.
Learn more
Speaker | Prof. Dr. Konrad Aden
Affiliation | Universitätsklinikum Schleswig-Holstein, Kiel, Germany
Host-microbial interactions as pathophysiological nexus in inflammatory bowel disease
In inflammatory bowel diseases, many patients do not respond to therapy or do not maintain disease control long-term. Precision medicine-based approaches to overcome the “therapeutic ceiling” are urgently needed. Immunometabolism is an important component to the pathophysiology of inflammatory bowel diseases and thus may serve the purpose of contributing to better and more personalized therapy decisions. While several metabolic pathways contribute, the talk puts special emphasis on the metabolism of the essential amino acid tryptophan.
Related videos
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer
Metabolomics as a tool to stratify patients and guide therapeutic decision
Related articles
- Data interpretation tools to unleash the full impact of metabolomics
- Linking your research question to relevant metabolite features in untargeted metabolomics profiles
- Metabolomics meets microbiome | Quantify the impact in microbiome research
- Amino acid auxotrophies in the human gut microbiome
- Gut metabolomic changes during pregnancy reveal the importance of GI region in sample collection
